The impact of obesity and insulin resistance on thyroid cancer: A systematic review

被引:25
作者
Harikrishna, Arya [1 ]
Ishak, Angela [1 ]
Ellinides, Andreas [1 ]
Saad, Richard [1 ]
Christodoulou, Haris [1 ]
Spartalis, Eleftherios [2 ]
Paschou, Stavroula A. [1 ,3 ]
机构
[1] European Univ Cyprus, Sch Med, Nicosia, Cyprus
[2] Univ Athens, Med Sch, Lab Expt Surg & Surg Res, Athens, Greece
[3] Univ Athens, Aghia Sophia Hosp, Med Sch, Div Endocrinol & Diabet, Athens 11527, Greece
关键词
Thyroid cancer; Obesity; Insulin resistance; Prevalence; Detection; Nodules; FACTOR-KAPPA-B; INCREASING INCIDENCE; MONONUCLEAR-CELLS; POOLED ANALYSIS; UNITED-STATES; BODY-SIZE; RISK; PREVALENCE; MUTATIONS; LEPTIN;
D O I
10.1016/j.maturitas.2019.03.022
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
In recent decades, there has been a marked increase in the prevalence of thyroid cancer. This phenomenon has paralleled the increase in the prevalence of obesity worldwide, which is associated with insulin resistance. Associations between these entities have been hypothesized, mainly for older and female populations, but they remain unclear. The aim of this article is to systematically review the literature in an attempt to determine whether the increase in the prevalence of thyroid cancer is due to obesity or due only to improved detection with the better imaging techniques available. A thorough literature search on PubMed and application of selection criteria identified 15 appropriate studies. The detailed analysis of the data from these studies indicated that there is a suggestive association between thyroid cancer, obesity, insulin resistance and hyperinsulinemia for both genders. Therefore, the increased prevalence of thyroid cancer is not dependent on improved detection only. Further research should be performed for complete understanding of the pathophysiological associations, especially regarding adipose tissue and genetics, but also for the improvement of preventive public health policies.
引用
收藏
页码:45 / 49
页数:5
相关论文
共 57 条
[1]   Is BMI the best measure of obesity? [J].
Adab, Peymane ;
Pallan, Miranda ;
Whincup, Peter H. .
BMJ-BRITISH MEDICAL JOURNAL, 2018, 360
[2]  
Alsina J, 2017, MOL IMAGING RADIONUC, V26, P102, DOI 10.4274/2017.26.suppl.12
[3]  
American Thyroid Association, 2016, THYR WEIGHT
[4]   High prevalence of papillary thyroid cancer in Korean women with insulin resistance [J].
Bae, Min Jung ;
Kim, Sang Soo ;
Kim, Won Jin ;
Yi, Yang Seon ;
Jeon, Yun Kyung ;
Kim, Bo Hyun ;
Lee, Byung Joo ;
Lee, Jin Choon ;
Kim, In Joo ;
Wang, Soo Geun ;
Kim, Yong Ki .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 (01) :66-71
[5]   Insulin Receptor Signaling in Normal and Insulin-Resistant States [J].
Boucher, Jeremie ;
Kleinridders, Andre ;
Kahn, C. Ronald .
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2014, 6 (01)
[6]   Drug Insight: the role of leptin in human physiology and pathophysiology - emerging clinical applications [J].
Brennan, Aoife M. ;
Mantzoros, Christos S. .
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2006, 2 (06) :318-327
[7]   Association of obesity and diabetes with thyroid nodules [J].
Buscemi, Silvio ;
Massenti, Fatima Maria ;
Vasto, Sonya ;
Galvano, Fabio ;
Buscemi, Carola ;
Corleo, Davide ;
Barile, Anna Maria ;
Rosafio, Giuseppe ;
Rini, Nadia ;
Giordano, Carla .
ENDOCRINE, 2018, 60 (02) :339-347
[8]   Increasing Incidence of Differentiated Thyroid Cancer in the United States, 1988-2005 [J].
Chen, Amy Y. ;
Jemal, Ahmedin ;
Ward, Elizabeth M. .
CANCER, 2009, 115 (16) :3801-3807
[9]   Clinicopathologic significance of leptin and leptin receptor expressions in papillary thyroid carcinoma [J].
Cheng, Shih-Ping ;
Chi, Chin-Wen ;
Tzen, Chi-Yuan ;
Yang, Tsen-Long ;
Lee, Jie-Jen ;
Liu, Tsang-Pai ;
Liu, Chien-Liang .
SURGERY, 2010, 147 (06) :847-853
[10]   Cellular senescence in aging and age-related disease: from mechanisms to therapy [J].
Childs, Bennett G. ;
Durik, Matej ;
Baker, Darren J. ;
van Deursen, Jan M. .
NATURE MEDICINE, 2015, 21 (12) :1424-1435